Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.

[1]  Hai-Yan Zhang,et al.  Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents. , 2012, Bioorganic & medicinal chemistry letters.

[2]  Jian-Dong Jiang,et al.  Synthesis, structure-activity relationship and biological evaluation of novel N-substituted matrinic acid derivatives as host heat-stress cognate 70 (Hsc70) down-regulators. , 2011, Bioorganic & medicinal chemistry letters.

[3]  Jian-Ping Zuo,et al.  Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. , 2011, Bioorganic & medicinal chemistry.

[4]  Chang-An Geng,et al.  Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents. , 2011, Bioorganic & medicinal chemistry.

[5]  Jian-Dong Jiang,et al.  Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70. , 2011, Journal of medicinal chemistry.

[6]  Chang-An Geng,et al.  Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents. , 2011, European journal of medicinal chemistry.

[7]  W. Lu,et al.  Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus. , 2010, Bioorganic & medicinal chemistry.

[8]  S. Yeh,et al.  Synthesis and the Biological Evaluation of Arylnaphthalene Lignans as Anti‐hepatitis B Virus Agents , 2010, Bioorganic & medicinal chemistry.

[9]  P. Zhan,et al.  Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors. , 2010, Mini reviews in medicinal chemistry.

[10]  K. Sato,et al.  Current and novel therapies for hepatitis B virus infection. , 2010, Mini reviews in medicinal chemistry.

[11]  Xiaohong Yang,et al.  2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly. , 2010, Bioorganic & medicinal chemistry letters.

[12]  Ji-Jun Chen,et al.  Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[13]  F. Zoulim,et al.  Hepatitis B virus resistance to nucleos(t)ide analogues. , 2009, Gastroenterology.

[14]  T. Geijtenbeek,et al.  The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. , 2009, Virology.

[15]  Po-Cheng Chiang,et al.  Anti-HBV and cytotoxic activities of pyranocoumarin derivatives. , 2009, Bioorganic & medicinal chemistry.

[16]  Peng Zhang,et al.  Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols. , 2009, Bioorganic & medicinal chemistry.

[17]  Y. Liaw.  HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B , 2009, Hepatology international.

[18]  Ji-Jun Chen,et al.  Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives. , 2009, Bioorganic & medicinal chemistry letters.

[19]  M. Hattori,et al.  Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases. , 2009, Bioorganic & medicinal chemistry.

[20]  Ji-Jun Chen,et al.  Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[21]  X. Zhai,et al.  Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro. , 2008, Bioorganic & medicinal chemistry.

[22]  Ji-Jun Chen,et al.  Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives. , 2008, Bioorganic & medicinal chemistry letters.

[23]  M. Rizzetto,et al.  Chronic HBV-related liver disease. , 2008, Molecular aspects of medicine.

[24]  Y. Li,et al.  Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue , 2007, Proceedings of the National Academy of Sciences.

[25]  K. Kitaura,et al.  Stereoselective synthesis of 3,6-disubstituted-3,6-dihydropyridin-2-ones as potential diketopiperazine mimetics using organocopper-mediated anti-SN2' reactions and their use in the preparation of low-molecule CXCR4 antagonists. , 2006, The Journal of organic chemistry.

[26]  P. Gong,et al.  Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates. , 2006, Bioorganic & medicinal chemistry.

[27]  S. Locarnini,et al.  Cellular and virological mechanisms of HBV drug resistance. , 2006, Journal of hepatology.

[28]  Y. Li,et al.  New targets and inhibitors of HBV replication to combat drug resistance. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  Chien-Jen Chen,et al.  Prevention of Hepatocellular Carcinoma by Universal Vaccination against Hepatitis B Virus: The Effect and Problems , 2005, Clinical Cancer Research.

[30]  D. Milich,et al.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection , 2003, Hepatology.

[31]  A. Detsky,et al.  Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.

[32]  H. Mitsuhashi,et al.  Studies on the Constituents of Asclepiadaceae Plants. XLVIII. 5α, 6α-Epoxycaudatin, a New Polyoxypregnane Derivative from Cynanchum caudatum MAX. , 1980 .